
Shanghai Henlius Biotech, Inc. 2696.HK
2696.HK
Shanghai Henlius Biotech, Inc. 1877.HK
Shanghai Junshi Biosciences Co., Ltd. 1548.HK
Genscript Biotech Corporation 6821.HK
Asymchem Laboratories (Tianjin) Co., Ltd. 2096.HK
Simcere Pharmaceutical Group Limited 1513.HK
Livzon Pharmaceutical Group Inc. 9688.HK
Zai Lab Limited 9606.HK
Duality Biotherapeutics, Inc. 6855.HK
Ascentage Pharma Group International 9995.HK
RemeGen Co., Ltd.
Shanghai Henlius Biotech, Inc. 1877.HK
Shanghai Junshi Biosciences Co., Ltd. 1548.HK
Genscript Biotech Corporation 6821.HK
Asymchem Laboratories (Tianjin) Co., Ltd. 2096.HK
Simcere Pharmaceutical Group Limited 1513.HK
Livzon Pharmaceutical Group Inc. 9688.HK
Zai Lab Limited 9606.HK
Duality Biotherapeutics, Inc. 6855.HK
Ascentage Pharma Group International 9995.HK
RemeGen Co., Ltd.
Performance
Periode | 2696.HK | 1877.HK | 1548.HK | 6821.HK | 2096.HK | 1513.HK | 9688.HK | 9606.HK | 6855.HK | 9995.HK |
---|---|---|---|---|---|---|---|---|---|---|
6M | 111.05 % | 84.41 % | 51.25 % | 107.42 % | 71.02 % | 25.34 % | -3.42 % | 52.19 % | 83.45 % | 177.33 % |
YTD | 204.89 % | 134.46 % | 60.02 % | 78.62 % | 91.52 % | 20.67 % | 12.69 % | 63.02 % | 55.77 % | 585.09 % |
1Y | 219.15 % | 81.60 % | 30.00 % | 55.48 % | 99.70 % | 13.88 % | 1.01 % | 63.02 % | 42.87 % | 494.27 % |
3Y | 427.61 % | 4.21 % | -13.19 % | -7.45 % | 43.48 % | 49.65 % | -7.87 % | 63.02 % | 358.00 % | 101.64 % |
5Y | 66.24 % | -48.31 % | 32.63 % | -66.17 % | 19.31 % | -10.50 % | -68.09 % | 63.02 % | 143.83 % | 32.31 % |
10Y | 44.89 % | 10.57 % | 1 091.67 % | -66.17 % | 19.31 % | 77.92 % | -63.90 % | 63.02 % | 81.25 % | 32.31 % |
Depuis le début | 44.89 % | 10.57 % | 1 091.67 % | -66.17 % | 19.31 % | 81.41 % | -63.90 % | 63.02 % | 81.25 % | 32.31 % |